These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 335209)

  • 1. The cytolytic attack mechanism of complement.
    Mayer MM
    Monogr Allergy; 1977; 12():1-12. PubMed ID: 335209
    [No Abstract]   [Full Text] [Related]  

  • 2. The properdin pathway: mechanisms of complement activation and analogies to the classical pathway.
    Fearon DT; Austen KF; Ruddy S
    Rheumatology; 1975; 6():2-16. PubMed ID: 1105744
    [No Abstract]   [Full Text] [Related]  

  • 3. [Complement activation and biological activities].
    Inoue K
    Nihon Saikingaku Zasshi; 1976 Jul; 31(4):535-55. PubMed ID: 988219
    [No Abstract]   [Full Text] [Related]  

  • 4. Clearances of complement components, C3 proactivator and other serum proteins in chronic membranoproliferative glomerulonephritis (CMPGN).
    Geiger H; Good RA; Day NK
    Clin Nephrol; 1975; 3(4):139-47. PubMed ID: 1149337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologically mediated membrane damage: the mechanism of complement action and the similarity of lymphocyte-mediated cytotoxicity.
    Mayer MM; Hammer CH; Michaels DW; Shin ML
    Transplant Proc; 1978 Dec; 10(4):707-14. PubMed ID: 366830
    [No Abstract]   [Full Text] [Related]  

  • 6. The reactivity of the complement system.
    Hadding U
    Monogr Allergy; 1977; 12():36-45. PubMed ID: 335218
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical applications of complement measurements in rheumatic diseases.
    Goldstein IM
    Am J Med Sci; 1975; 269(2):172-82. PubMed ID: 1096603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement-induced ultrastructural membrane lesions: requirement for terminal components.
    Packman CH; Rosenfeld SI; Weed RI; Leddy JP
    J Immunol; 1976 Nov; 117(5 Pt.2):1883-9. PubMed ID: 993584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restriction of complement-mediated membrane damage by the eighth component of complement: a dual role for C8 in the complement attack sequence.
    Nemerow GR; Yamamoto KI; Lint TF
    J Immunol; 1979 Sep; 123(3):1245-52. PubMed ID: 469249
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Freeze-thaw activation of the complement attack phase: II. Comparison of convertase generated C--56 with C--56 generated by freezing and thawing.
    Dessauer A; Rother U; Rother K
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():83-8. PubMed ID: 6444196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolysis of the C5b-7 complex: cleavage of the C5b and C6 subunits and its effect on the interaction of the complex with phospholipid bilayers.
    Yamamoto KI
    J Immunol; 1980 Oct; 125(4):1745-50. PubMed ID: 6997387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system.
    Nicholson-Weller A; Burge J; Fearon DT; Weller PF; Austen KF
    J Immunol; 1982 Jul; 129(1):184-9. PubMed ID: 6211481
    [No Abstract]   [Full Text] [Related]  

  • 14. Complement lysis: the ultrastructure and orientation of the C5b-9 complex on target sheep erythrocyte membranes.
    Tranum-Jensen J; Bhakdi S; Bhakdi-Lehnen B; Bjerrum OJ; Speth V
    Scand J Immunol; 1978; 7(1):45-6. PubMed ID: 635472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane attack complex of complement: generation of high-affinity phospholipid binding sites by fusion of five hydrophilic plasma proteins.
    Podack ER; Biesecker G; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):897-901. PubMed ID: 284414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terminal complement components play a role in the expression of C5a.
    Gresham HD; Renfer L; Hammer CH; Frank MM
    J Immunol; 1987 Feb; 138(3):838-41. PubMed ID: 3805718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypochlorite-induced alterations to canine serum complement.
    Boyer JT; Wyde P; Bier M
    Clin Exp Immunol; 1975 Aug; 21(2):345-50. PubMed ID: 1102168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complement system].
    Korol' SA
    Fiziol Zh; 1977; 23(3):408-16. PubMed ID: 326583
    [No Abstract]   [Full Text] [Related]  

  • 19. Freeze-thaw activation of the complement attack phase: I. Separation of two steps in the formation of the active C--56 complex.
    Dessauer A; Rother U; Rother K
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():75-81. PubMed ID: 6587745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation and function of the classical and alternative pathways of complement.
    Ogle JD; Ogle CK
    Clin Physiol Biochem; 1983; 1(2-5):194-213. PubMed ID: 6241120
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.